Watch for New DOAC Guidance in Your Anticoagulation Policies
February 2019
You'll see more focus on maximizing safe use of direct oral anticoagulants (DOACs)...apixaban (Eliquis), etc.
The Joint Commission is expanding the anticoagulation National Patient Safety Goal (NPSG) starting July 1, 2019. The biggest change will be the addition of the DOACs.
Verify your policy addresses DOAC dosing, monitoring, interactions, etc...similar to what you have for warfarin and injectable anticoagulants.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote